Molecular Profile | Unknown unknown |
Therapy | Enadenotucirev |
Indication/Tumor Type | colorectal cancer |
Response Type | not applicable |
Create By | tyin |
Update By | smockus |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | colorectal cancer | not applicable | Enadenotucirev | Phase I | Actionable | In a Phase I trial, Enadenotucirev demonstrated safety and uptake by tumor cells in metastatic colorectal cancer patients (Ann Oncol (2014) 25 (suppl 4): iv367). | detail... |
---|
PubMed Id | Reference Title | Details |
---|---|---|
A PHASE 1 STUDY OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS, ADMINISTERED INTRAVENOUSLY - ANALYSIS OF DOSE EXPANSION AND REPEAT CYCLE COHORTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) | Full reference... |